A detailed history of Pacific Capital Wealth Advisors, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pacific Capital Wealth Advisors, Inc holds 19 shares of REGN stock, worth $17,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 17 11.76%
Holding current value
$17,641
Previous $17,000 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$1024.09 - $1201.76 $2,048 - $2,403
2 Added 11.76%
19 $19,000
Q2 2024

Aug 06, 2024

BUY
$883.2 - $1071.19 $15,014 - $18,210
17 New
17 $17,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $99.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Pacific Capital Wealth Advisors, Inc Portfolio

Follow Pacific Capital Wealth Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Capital Wealth Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Capital Wealth Advisors, Inc with notifications on news.